Wolfgang Sieghart

Wolfgang Sieghart

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Treatment patterns of eosinophilic esophagitis in the biologic era-a real-world analysis.

Treatment patterns of eosinophilic esophagitis in the biologic era-a real-world analysis.

Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus

Published: July 02, 2025

Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.

Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.

Journal: The Lancet. Oncology

Published: August 14, 2021

Cancer and hepatic steatosis.

Cancer and hepatic steatosis.

Journal: ESMO open

Published: March 29, 2021

Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation.

Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation.

Journal: Hepatology communications

Published: March 01, 2021

C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation.

C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation.

Journal: PloS one

Published: March 10, 2019

Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma.

Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma.

Journal: United European gastroenterology journal

Published: December 12, 2018

Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort.

Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort.

Journal: Alimentary pharmacology & therapeutics

Published: December 10, 2018

Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?

Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?

Journal: Memo

Published: June 09, 2018

Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral Hepatitis.

Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral Hepatitis.

Journal: Ultrasound in medicine & biology

Published: May 03, 2018

Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma.

Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: April 27, 2018

Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma.

Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma.

Journal: Liver cancer

Published: December 26, 2017

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study.

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study.

Journal: The Lancet. Oncology

Published: November 14, 2017

Showing 1-12 of 50

Last Updated: 09/26/2026